Retrospective Study of Airway Management in Dutch ED's
ConditionEndotracheal Intubation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFrisius Medisch Centrum
About this trial
Describing characteristics of the practice of airway management in Dutch emergency departments, including information about patient demographics, indications, performer characteristics, equipment and medication used and complications due to intubation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's
Disqualifiers
Patients for which no information about the intubation can be found in the electronic patient chart will be excluded from the study.
Trial population
All patients who underwent endotracheal intubation between 01-01-2019 and 31-12-2023 in the participating ED's (Leeuwarden Medical Centre, VieCuri Medical Centre, Catharina Hospital, Rijnstate Hospital, Zuyderland Medical Centre)
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Endotracheal intubation
Procedure/SurgeryAll endotracheal intubations carried out in the emergency department of one of the participating hospitals in the time period 01-01-2019 - 31-12-2023
Treatment groups
1,000 Participants
are divided into 1 treatment groupGroup A: patients who underwent the intervention of endotracheal intubation1 intervention
Trial outcomes
Primary outcomes
1
Different complications of endotracheal intubation
* significant decrease of SpO2. Defined as: desaturation of \>10% from baseline or as defined by the treating physician * significant decrease of blood pressure. Defined as: systolic pressure \<90mmHg with a drop of \>20% from baseline or as defined by the treating physician. * significant increase of blood pressure. Defined as: systolic pressure \> 160mmHg with a rise of \>20% from baseline, or as defined by the treating physician. * significant bradycardia. Defined as: heart rate \< 40/min and a drop of \> 20% from baseline, or as defined by the treating physician. * significant tachycardia. Defined as: heart rate \> 160/min and a rise of \> 20% from baseline, or as defined by the treating physician. * dental or airway trauma * oesophageal or mainstem bronchial intubation * vomiting or aspiration * laryngospasm * equipment failure * medication error * cardiac arrest * failed attempt / need for an emergency surgical airway * other
Time frame
At the time of intervention and consequent 1 hourOther outcomes
1
Intubator characteristics
Specialty and function/seniority of the intubator
Time frame
At the time of intervention and consequent 1 hour2
Indication for intubation
Indications could be: Trauma Burns Drowning Overdose/ingestion Respiratory failure Cardiac arrest (active cardiac arrest) Post-cardiac arrest Stroke Seizure Altered mental status due to other cause (if altered mental status due to stroke, intoxication, seizure or post-cardiac arrest then score as the primary cause) Sepsis Cardiac failure Airway obstruction GI bleed Anaphylaxis Other
Time frame
At the time of intervention and consequent 1 hour3
Sedation agent used
Ketamine, etomidate, propofol, midazolam
Time frame
At the time of intervention and consequent 1 hour4
Paralytic agent used
Rocuronium / Succinylcholine
Time frame
At the time of intervention and consequent 1 hourSponsors and contacts
Click on the lead sponsor to view all of their trials.
Frisius Medisch Centrum
Lead sponsor
VieCuri Medical Centre
Collaborator
Catharina Ziekenhuis Eindhoven
Collaborator
Rijnstate Hospital
Collaborator
Zuyderland Medical Centre
Collaborator
Source ClinicalTrials.gov